GPR89A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.473400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.884040E-01
Normal-vs-Stage2
2.604400E-01
Normal-vs-Stage3
7.662000E-01
Normal-vs-Stage4
5.538000E-02
Stage1-vs-Stage2
5.944000E-01
Stage1-vs-Stage3
2.220800E-01
Stage1-vs-Stage4
9.412400E-01
Stage2-vs-Stage3
1.034790E-01
Stage2-vs-Stage4
5.281600E-01
Stage3-vs-Stage4
8.738400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.661800E-01
Normal-vs-AfricanAmerican
9.112500E-02
Normal-vs-Asian
4.298200E-02
Caucasian-vs-AfricanAmerican
2.829600E-01
Caucasian-vs-Asian
3.425600E-01
AfricanAmerican-vs-Asian
8.174800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.130800E-01
Normal-vs-Female
3.067600E-01
Male-vs-Female
3.134600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.293600E-01
Normal-vs-Age(41-60Yrs)
1.552200E-01
Normal-vs-Age(61-80Yrs)
3.100400E-01
Normal-vs-Age(81-100Yrs)
2.492300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.789820E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.422400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.411800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.909600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.878600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.199200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.050600E-01
Normal-vs-Daily Drinker
5.176400E-01
Normal-vs-Weekly Drinker
1.562420E-02
Normal-vs-Occasional Drinker
6.119800E-02
Normal-vs-Social Drinker
2.257200E-01
Non Drinker-vs-Daily Drinker
2.001800E-01
Non Drinker-vs-Weekly Drinker
6.031200E-01
Non Drinker-vs-Occasional Drinker
4.619000E-01
Non Drinker-vs-Social Drinker
7.028400E-01
Daily Drinker-vs-Weekly Drinker
9.388000E-02
Daily Drinker-vs-Occasional Drinker
2.522000E-02
Daily Drinker-vs-Social Drinker
3.635000E-01
Weekly Drinker-vs-Occasional Drinker
9.250800E-01
Weekly Drinker-vs-Social Drinker
3.806600E-01
Occasional Drinker-vs-Social Drinker
2.025600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.170800E-01
Normal-vs-Grade 2
8.690400E-01
Normal-vs-Grade 3
8.636400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.719600E-01
Grade 1-vs-Grade 3
4.783800E-01
Grade 1-vs-Grade 4
9.170800E-01
Grade 2-vs-Grade 3
9.166000E-01
Grade 2-vs-Grade 4
8.690400E-01
Grade 3-vs-Grade 4
8.636400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.095400E-01
Normal-vs-NonDiabetic
1.810780E-01
Diabetic-vs-NonDiabetic
7.390000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.678400E-02
Normal-vs-NoPancreatitis
2.873600E-01
Pancreatitis-vs-NoPancreatitis
5.443400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.222440E-01
Normal-vs-N1
3.168200E-01
N0-vs-N1
2.097600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.179480E-04
Normal-vs-TP53-NonMutant
2.384300E-03
TP53-Mutant-vs-TP53-NonMutant
3.780300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
